Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response to anti-EGFR therapies show disease progression wit...
Enregistré dans:
Auteurs principaux: | Sumitra Mohan, Ellen Heitzer, Peter Ulz, Ingrid Lafer, Sigurd Lax, Martina Auer, Martin Pichler, Armin Gerger, Florian Eisner, Gerald Hoefler, Thomas Bauernhofer, Jochen B Geigl, Michael R Speicher |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ca1ee54617a7403a9ad5c1ba8a23efa6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
par: Peter Ulz, et autres
Publié: (2016) -
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
par: Peter Ulz, et autres
Publié: (2019) -
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
par: Peter Ulz, et autres
Publié: (2020) -
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
par: Beth O. Van Emburgh, et autres
Publié: (2016) -
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
par: Joanna Szkandera, et autres
Publié: (2013)